CN103435555B - Preparation method of 4-chloro-5-methylpyrimidine - Google Patents
Preparation method of 4-chloro-5-methylpyrimidine Download PDFInfo
- Publication number
- CN103435555B CN103435555B CN201310376770.1A CN201310376770A CN103435555B CN 103435555 B CN103435555 B CN 103435555B CN 201310376770 A CN201310376770 A CN 201310376770A CN 103435555 B CN103435555 B CN 103435555B
- Authority
- CN
- China
- Prior art keywords
- chloro
- methylpyrimidine
- methyl
- hydrazinopyrimidine
- mass parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 19
- RPDVPWWBNQKLAS-UHFFFAOYSA-N 4-chloro-5-methylpyrimidine Chemical compound CC1=CN=CN=C1Cl RPDVPWWBNQKLAS-UHFFFAOYSA-N 0.000 title abstract description 12
- 238000006243 chemical reaction Methods 0.000 claims abstract description 37
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims abstract description 26
- 238000003756 stirring Methods 0.000 claims abstract description 21
- 239000002904 solvent Substances 0.000 claims abstract description 17
- 239000012153 distilled water Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 16
- 239000012065 filter cake Substances 0.000 claims abstract description 13
- 239000003208 petroleum Substances 0.000 claims abstract description 13
- NWZSZGALRFJKBT-KNIFDHDWSA-N (2s)-2,6-diaminohexanoic acid;(2s)-2-hydroxybutanedioic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O.NCCCC[C@H](N)C(O)=O NWZSZGALRFJKBT-KNIFDHDWSA-N 0.000 claims abstract description 10
- IKDUDTNKRLTJSI-UHFFFAOYSA-N hydrazine monohydrate Substances O.NN IKDUDTNKRLTJSI-UHFFFAOYSA-N 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 8
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 claims abstract description 7
- 238000001816 cooling Methods 0.000 claims abstract description 7
- 238000001514 detection method Methods 0.000 claims abstract description 7
- 239000000706 filtrate Substances 0.000 claims abstract description 7
- 238000004809 thin layer chromatography Methods 0.000 claims abstract description 7
- 238000004140 cleaning Methods 0.000 claims abstract description 6
- 239000000047 product Substances 0.000 claims abstract description 6
- APRMCBSTMFKLEI-UHFFFAOYSA-N 2-chloro-5-methylpyrimidine Chemical compound CC1=CN=C(Cl)N=C1 APRMCBSTMFKLEI-UHFFFAOYSA-N 0.000 claims description 30
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 18
- 230000015572 biosynthetic process Effects 0.000 claims description 17
- 238000003786 synthesis reaction Methods 0.000 claims description 17
- 238000000967 suction filtration Methods 0.000 claims description 12
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical group CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 8
- 239000002244 precipitate Substances 0.000 claims description 8
- 230000006837 decompression Effects 0.000 claims description 6
- 238000010792 warming Methods 0.000 claims description 6
- 238000002156 mixing Methods 0.000 claims description 3
- 239000000284 extract Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- OCQKKFDHCVWZFF-UHFFFAOYSA-N (6-chloro-5-methylpyrimidin-4-yl)hydrazine Chemical compound CC1=C(Cl)N=CN=C1NN OCQKKFDHCVWZFF-UHFFFAOYSA-N 0.000 abstract description 6
- NUEYDUKUIXVKNB-UHFFFAOYSA-N 4,6-dichloro-5-methylpyrimidine Chemical compound CC1=C(Cl)N=CN=C1Cl NUEYDUKUIXVKNB-UHFFFAOYSA-N 0.000 abstract description 5
- 238000005406 washing Methods 0.000 abstract description 5
- 238000001914 filtration Methods 0.000 abstract 2
- UKWHYYKOEPRTIC-UHFFFAOYSA-N mercury(ii) oxide Chemical compound [Hg]=O UKWHYYKOEPRTIC-UHFFFAOYSA-N 0.000 abstract 2
- 238000001704 evaporation Methods 0.000 abstract 1
- 238000010438 heat treatment Methods 0.000 abstract 1
- 229940101209 mercuric oxide Drugs 0.000 abstract 1
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 5
- 238000005160 1H NMR spectroscopy Methods 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 229910000564 Raney nickel Inorganic materials 0.000 description 4
- 238000002386 leaching Methods 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- SVUOLADPCWQTTE-UHFFFAOYSA-N 1h-1,2-benzodiazepine Chemical compound N1N=CC=CC2=CC=CC=C12 SVUOLADPCWQTTE-UHFFFAOYSA-N 0.000 description 1
- 206010016654 Fibrosis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 108010062740 TRPV Cation Channels Proteins 0.000 description 1
- 102000003566 TRPV1 Human genes 0.000 description 1
- 102100029613 Transient receptor potential cation channel subfamily V member 1 Human genes 0.000 description 1
- 101150016206 Trpv1 gene Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 239000007806 chemical reaction intermediate Substances 0.000 description 1
- 238000010960 commercial process Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical class [H]* 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Description
Claims (3)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310376770.1A CN103435555B (en) | 2013-08-27 | 2013-08-27 | Preparation method of 4-chloro-5-methylpyrimidine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310376770.1A CN103435555B (en) | 2013-08-27 | 2013-08-27 | Preparation method of 4-chloro-5-methylpyrimidine |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103435555A CN103435555A (en) | 2013-12-11 |
CN103435555B true CN103435555B (en) | 2015-06-24 |
Family
ID=49689300
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310376770.1A Active CN103435555B (en) | 2013-08-27 | 2013-08-27 | Preparation method of 4-chloro-5-methylpyrimidine |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103435555B (en) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB854011A (en) * | 1958-09-10 | 1960-11-16 | Ici Ltd | New pyrimidines |
WO1993018011A1 (en) * | 1992-03-06 | 1993-09-16 | Dowelanco | Process for the preparation of 2-alkylthio-4-hydrazino-5-fluoropyrimidines |
JP2010077066A (en) * | 2008-09-25 | 2010-04-08 | Fujifilm Corp | Method for producing 5-aminopyrazole derivative |
CN102171202A (en) * | 2008-10-06 | 2011-08-31 | 癌症研究技术有限公司 | Pyridine and pyrimidine based compounds as WNT signaling pathway inhibitors for the treatment of cancer |
-
2013
- 2013-08-27 CN CN201310376770.1A patent/CN103435555B/en active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB854011A (en) * | 1958-09-10 | 1960-11-16 | Ici Ltd | New pyrimidines |
WO1993018011A1 (en) * | 1992-03-06 | 1993-09-16 | Dowelanco | Process for the preparation of 2-alkylthio-4-hydrazino-5-fluoropyrimidines |
JP2010077066A (en) * | 2008-09-25 | 2010-04-08 | Fujifilm Corp | Method for producing 5-aminopyrazole derivative |
CN102171202A (en) * | 2008-10-06 | 2011-08-31 | 癌症研究技术有限公司 | Pyridine and pyrimidine based compounds as WNT signaling pathway inhibitors for the treatment of cancer |
Non-Patent Citations (2)
Title |
---|
2-烃基喹噁啉的合成;袁国淦等;《南京大学学报(自然科学版)》;19821231(第3期);669-677 * |
3-氯-5-甲基哒嗪的合成研究;赵春深等;《化学试剂》;20091231;第31卷(第10期);819-850 * |
Also Published As
Publication number | Publication date |
---|---|
CN103435555A (en) | 2013-12-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006114202A1 (en) | Method for the production of 5-(4-[4-(5-cyano-3-indolyl)-butyl]-1-piperazinyl)-benzofuran-2-carboxamide | |
CN103694176B (en) | Preparation method of nilotinib intermediate | |
CN107129470A (en) | A kind of synthesis of minoxidil and process for purification | |
CN105085484B (en) | A kind of preparation method of Vonoprazan fumarate | |
CN105198821B (en) | Lip river former times replaces the preparation method of Buddhist nun | |
CN103435555B (en) | Preparation method of 4-chloro-5-methylpyrimidine | |
CN106946887B (en) | A kind of preparation method introducing catalyst optimization synthesis Dipyridamole | |
CN102321016A (en) | Synthesis method of 5-bromo-2-methyl 4-hydroxypyridinecarboxylate | |
CN106749098B (en) | A kind of preparation method preparing dioxopromethazine hydrochloride using oxygen as oxidant | |
CN110305067A (en) | A kind of optimum synthesis technique of anticancer drug Dacarbazine | |
CN103265085B (en) | Method for preparing platinum dioxide by adopting liquid phase process | |
CN106831648B (en) | The synthetic method of diazoxiide | |
CN105859608B (en) | A method of preparing half tartrate crystal form B of piperazine Ma Selin | |
CN105801462A (en) | (4S)-N-Boc-4-methoxymethyl-L-proline synthesis method | |
CN103864787B (en) | A kind of green synthesis method of 'Beta '-carboline compound | |
CN102234262B (en) | Method for preparing caffeic acid hydroxycoumarin ester compounds | |
CN106928301A (en) | A kind of preparation method of the androstenedione of 19 demethyl 4 | |
AU2016102264A4 (en) | Dyphylline pharmaceutical drug 7- (2,3-dihydroxypropyl) – theophylline synthesis method | |
CN102690211B (en) | The preparation method of tolvaptan intermediate | |
CN104387385B (en) | 6-carboxylate methyl ester-2-oxygen-7-azaindole and preparation method thereof and application | |
CN104478851A (en) | Method for preparing articaine hydrochloride | |
CN104829571A (en) | Escitalopram oxalate related substance and preparation method thereof | |
CN105777852A (en) | Deflazacort synthetic method | |
CN104098564A (en) | Pyrazol pyridine compound and preparation method thereof | |
CN106632070A (en) | Preparation method for chlorbipram PDE4-inhibitor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: 550014, 388, new material industrial park, Baiyun District, Guizhou, Guiyang Applicant after: GUIZHOU WYLTON JINGLIN ELECTRONIC MATERIAL CO.,LTD. Address before: 550014, 388, new material industrial park, Baiyun District, Guizhou, Guiyang Applicant before: Guizhou Wylton Jinglin Electronic Materials Co.,Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: GUIZHOU WYLTON JINLIN ELECTRONIC MATERIALS CO., LTD. TO: GUIZHOU WYLTON JINGLIN ELECTRONIC MATERIALS CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A preparation method of 4-chloro-5-methylpyrimidine Effective date of registration: 20211103 Granted publication date: 20150624 Pledgee: Guiyang Jinyang sub branch of China Construction Bank Co.,Ltd. Pledgor: GUIZHOU WYLTON JINGLIN ELECTRONIC MATERIAL CO.,LTD. Registration number: Y2021520000016 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20230704 Granted publication date: 20150624 Pledgee: Guiyang Jinyang sub branch of China Construction Bank Co.,Ltd. Pledgor: GUIZHOU WYLTON JINGLIN ELECTRONIC MATERIAL CO.,LTD. Registration number: Y2021520000016 |